Skip to main content
For credit card payments please select in store pick up/pay at store and you will be contacted for payment/shipping info!
Close this alert
Preorder
The Miracle Century: Making Sense of the Cell Therapy Revolution

The Miracle Century: Making Sense of the Cell Therapy Revolution

Current price: $30.00
Publication Date: August 27th, 2024
Publisher:
Harper
ISBN:
9780063288973
Pages:
272
Available for Preorder

Description

New York Times bestselling author and former FDA Commissioner Scott Gottlieb provides a glimpse of a promising future that is quickly approaching: a world with cures for chronic illnesses and cancers.

While traditional drugs mostly help us manage the effects of disease, cell therapies promise genuine cures for a broad range of intractable ailments, from Alzheimer’s to heart damage to cancer. They could even reverse the effects of aging. For the first time in history, on an unprecedented scale, we possess the power to modify the biology that gives rise to disease, ultimately restoring individuals to a state of normalcy and reversing debilitating ailments.

In The Miracle Century, former FDA Commissioner Scott Gottlieb traces the scientific achievements that propelled progress in cell therapies. The birth of this medical revolution wasn’t a sudden event. Rather, it emerged from decades of steady, incremental progress in science. These concerted advances made cell therapies a reality. To forge a path for continued medical breakthroughs, Dr. Gottlieb meticulously traces this scientific journey, identifying lessons on how these achievements can be replicated.

The MIracle Century is a look at the future of healthcare from one of the nation’s leading medical authorities. Scott Gottlieb explains how these new medicines are moving from the laboratory bench to the marketplace and tackles the issues that must be addressed to enable wide adoption of these treatments and transform as many lives as possible.

About the Author

Dr. Scott Gottlieb served as the twenty-third commissioner of the US Food and Drug Administration and is a resident fellow at the American Enterprise Institute. He is a regular contributor to the business news channel CNBC and a partner at the venture capital firm New Enterprise Associates. Dr. Gottlieb serves on the board of directors of the pharmaceutical company Pfizer Inc. and the genomic sequencing company Illumina, Inc. Fortune magazine has recognized him as one of the “World’s 50 Greatest Leaders,” and Time magazine has named him one of its “50 People Transforming Healthcare.” A graduate of Wesleyan University and the Mount Sinai School of Medicine, Dr. Gottlieb is an elected member of the National Academy of Medicine. He lives with his family in Westport, Connecticut.